<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50094</article-id><article-id pub-id-type="doi">10.7554/eLife.50094</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Vasohibin1, a new mouse cardiomyocyte IRES trans-acting factor that regulates translation during early hypoxia</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-149288"><name><surname>Hantelys</surname><given-names>Fransky</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106364"><name><surname>Godet</surname><given-names>Anne-Claire</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149285"><name><surname>David</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106365"><name><surname>Tatin</surname><given-names>Florence</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106366"><name><surname>Renaud-Gabardos</surname><given-names>Edith</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106367"><name><surname>Pujol</surname><given-names>Françoise</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149286"><name><surname>Diallo</surname><given-names>Leila H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106368"><name><surname>Ader</surname><given-names>Isabelle</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54331"><name><surname>Ligat</surname><given-names>Laetitia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106369"><name><surname>Henras</surname><given-names>Anthony K</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149287"><name><surname>Sato</surname><given-names>Yasufumi</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106371"><name><surname>Parini</surname><given-names>Angelo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106370"><name><surname>Lacazette</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106372"><name><surname>Garmy-Susini</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-84599"><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5282-3776</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">I2MC</institution>, <institution>Inserm UMR 1048</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution content-type="dept">Stromalab</institution>, <institution>Inserm U1031</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">CRCT</institution>, <institution>Inserm UMR 1037</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">Centre de Biologie Intégrative</institution>, <institution>Université Paul Sabatier</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution content-type="dept">Department of Vascular Biology, Institute of Development, Aging and Cancer</institution>, <institution>Tohoku Universtiy</institution>, <addr-line><named-content content-type="city">Sendai</named-content></addr-line>, <country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1184"><name><surname>Sonenberg</surname><given-names>Nahum</given-names></name><role>Reviewing editor</role><aff><institution>McGill University</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>anne-catherine.prats@inserm.fr</email> (AP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>12</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e50094</elocation-id><history><date date-type="received"><day>10</day><month>07</month><year>2019</year></date><date date-type="accepted"><day>09</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Hantelys et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Hantelys et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50094-v1.pdf"/><abstract><p>Hypoxia, a major inducer of angiogenesis, triggers major changes of gene expression at the transcriptional level. Furthermore, global protein synthesis is blocked while internal ribosome entry sites (IRES) allow specific mRNAs to be translated. Here we report the transcriptome and translatome signatures of (lymph)angiogenic genes in hypoxic HL-1 mouse cardiomyocytes: most genes are induced at the translatome level, including all IRES-containing mRNAs. Our data reveal activation of (lymph)angiogenic factor mRNA IRESs in early hypoxia. We identify vasohibin1 (VASH1) as an IRES trans-acting factor (ITAF) able to bind RNA and to activate the FGF1 IRES in hypoxia while it tends to inhibit several IRESs in normoxia. VASH1 depletion has also a wide impact on the translatome of (lymph)angiogenesis genes, suggesting that this protein can regulate translation positively or negatively in early hypoxia. Translational control thus appears as a pivotal process to trigger new vessel formation in ischemic heart.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Region  Midi-Pyrenees</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004923</institution-id><institution>AFM-Téléthon</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Renaud-Gabardos</surname><given-names>Edith</given-names></name><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Association pour la Recherche sur le Cancer</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>REFBIO VEMT</award-id><principal-award-recipient><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Fondation Toulouse Cancer-Sante</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Garmy-Susini</surname><given-names>Barbara</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-18-CE11-0020-RIBOCARD</award-id><principal-award-recipient><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004099</institution-id><institution>Ligue Contre le Cancer</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hantelys</surname><given-names>Fransky</given-names></name><name><surname>Godet</surname><given-names>Anne-Claire</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Lentivector plasmid complete maps and sequences  are available on Dryad.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Hantelys F</collab><collab>Godet A</collab><collab>David F</collab><collab>Tatin F</collab><collab>Renaud-Gabardos E</collab><collab>Pujol F</collab><collab>Diallo L</collab><collab>ADER I</collab><collab>Ligat L</collab><collab>Henras A</collab><collab>Sato Y</collab><collab>Parini A</collab><collab>Lacazette E</collab><collab>Garmy-Susini B</collab><collab>Prats A</collab></person-group><year iso-8601-date="2019">2019</year><source>Data from: Vasohibin1, a new IRES trans-acting factor for induction of (lymph)angiogenic factors in early hypoxia</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.2330r1b">https://dx.doi.org/10.5061/dryad.2330r1b</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.2330r1b</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-50094-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>